Effective Jul 16, 2008MGL c.111, § 3 MGL c.111LDepartment of Public Health
105 CMR 960.000 is set forth for the purpose of interpreting and implementing M.G.L. c.111L, Biotechnology, as enacted under Chapter 27 of the Acts of 2005, An Act Enhancing Regenerative Medicine in the Commonwealth.